Beijing, China

Dongyang Wu

This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Chemclin Diagnostics Co., Ltd.. Active years: 2021-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dongyang Wu. Retrieved from https://idiyas.com/inventor/dongyang-wu-53qjxih4

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 5.3

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2021-2025

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Dongyang Wu in Chemiluminescence Technology

Introduction

Dongyang Wu is a prominent inventor based in Beijing, China. He has made significant contributions to the field of light-initiated chemiluminescence technology. With a total of two patents to his name, Wu's work focuses on improving immunoassay methods and systems.

Latest Patents

Wu's latest patents include a method, system, reagent kit, and device for determining HD-hook-effect samples in immunoassays. This innovation is particularly relevant in the technical field of chemiluminescence technology. His work aims to enhance the accuracy and reliability of immunoassays, which are crucial in various diagnostic applications.

Career Highlights

Dongyang Wu is currently employed at Chemclin Diagnostics Co., Ltd. His role at the company allows him to apply his expertise in developing advanced diagnostic technologies. His contributions have been instrumental in pushing the boundaries of what is possible in the field of immunoassays.

Collaborations

Wu collaborates with notable colleagues, including Zifu Lian and Yuhui Liu. Their combined efforts contribute to the innovative projects at Chemclin Diagnostics Co., Ltd.

Conclusion

Dongyang Wu's work in chemiluminescence technology and immunoassays showcases his dedication to advancing medical diagnostics. His patents reflect a commitment to innovation that benefits the healthcare industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…